Amgen Inc Stock Revenue
| AMG Stock | 258.45 1.05 0.40% |
Amgen Inc fundamentals help investors to digest information that contributes to Amgen's financial success or failures. It also enables traders to predict the movement of Amgen Stock. The fundamental analysis module provides a way to measure Amgen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Amgen stock.
Amgen |
Amgen Inc Company Revenue Analysis
Amgen's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Amgen Revenue | 26.32 B |
Most of Amgen's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amgen Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Amgen Inc reported 26.32 B of revenue. This is 245.14% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers-General industry. The revenue for all Germany stocks is 179.0% lower than that of the firm.
Amgen Inc is the top company in revenue category among its peers. Market size based on revenue of Drug Manufacturers-General industry is presently estimated at about 28.96 Billion. Amgen totals roughly 26.32 Billion in revenue claiming about 91% of equities under Drug Manufacturers-General industry.Amgen Fundamentals
| Return On Equity | 1.26 | |||
| Return On Asset | 0.0997 | |||
| Profit Margin | 0.25 % | |||
| Operating Margin | 0.38 % | |||
| Current Valuation | 163.09 B | |||
| Shares Outstanding | 533.98 M | |||
| Shares Owned By Insiders | 0.20 % | |||
| Shares Owned By Institutions | 79.90 % | |||
| Price To Book | 39.21 X | |||
| Price To Sales | 5.06 X | |||
| Revenue | 26.32 B | |||
| Gross Profit | 19.92 B | |||
| EBITDA | 8.75 B | |||
| Net Income | 6.55 B | |||
| Total Debt | 37.35 B | |||
| Book Value Per Share | 6.86 X | |||
| Cash Flow From Operations | 9.72 B | |||
| Earnings Per Share | 11.27 X | |||
| Price To Earnings To Growth | 1.53 X | |||
| Number Of Employees | 25.2 K | |||
| Beta | 0.63 | |||
| Market Capitalization | 118.32 B | |||
| Total Asset | 65.12 B | |||
| Z Score | 1.8 | |||
| Annual Yield | 0.04 % | |||
| Net Asset | 65.12 B | |||
| Last Dividend Paid | 7.76 |
About Amgen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Amgen Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amgen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amgen Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Amgen Stock Analysis
When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.